| Dr Fabian De Santiago, PHARM D | |
|
4016 S Highway 97, Sand Springs, OK 74063-3812 | |
| (918) 245-6661 | |
| Not Available |
| Full Name | Dr Fabian De Santiago |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 4016 S Highway 97, Sand Springs, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508472481 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 18931 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fabian De Santiago, PHARM D 4016 S Highway 97, Sand Springs, OK 74063-3812 Ph: (918) 245-6661 | Dr Fabian De Santiago, PHARM D 4016 S Highway 97, Sand Springs, OK 74063-3812 Ph: (918) 245-6661 |
News Archive
Patients who go to UPMC Presbyterian for heart catheterization and who receive a stent to treat clogged arteries are now being screened with a simple blood test to determine if they have a gene variant that makes them less likely to respond to a blood-thinning medication commonly prescribed after the procedure.
Reducing community transmission and changing behaviour in communities is key to containing Ebola outbreaks, according to new research into the first known outbreak of the virus in 1976 by researchers at the London School of Hygiene & Tropical Medicine and Fogarty International Center at the National Institutes of Health.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Aztreonam for Injection, USP in two dosage strengths. Aztreonam is therapeutically equivalent to the reference-listed drug Azactam, which is marketed by Bristol-Myers Squibb.
Amgen is pleased to announce that it has won the Best New Drug award for Prolia™ (denosumab), a novel treatment approved in the United States (U.S.) for women with postmenopausal osteoporosis at high risk for fracture, at the 2010 Scrip Awards ceremony Nov. 4 in London. Named one of TIME's Top 10 Medical Breakthroughs of 2009, Prolia is the first treatment specifically designed to target osteoclasts, the cells that break down bone.
› Verified 1 days ago
Kayla Marie Owens, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 E 2nd St, Sand Springs, OK 74063 Phone: 918-246-0510 | |
Kelley Cheek, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 E 2nd St, Sand Springs, OK 74063 Phone: 918-246-0510 | |
Adaobi Ezenwa, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 S State Highway 97, Sand Springs, OK 74063 Phone: 918-245-9523 | |
Dr. Rene Nicole Adkins, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 E 2nd St, Sand Springs, OK 74063 Phone: 918-246-0510 Fax: 918-246-0619 | |
Jeff Burkle, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4016 S Highway 97, Sand Springs, OK 74063 Phone: 918-245-6661 Fax: 918-245-4843 | |
Dr. Mary Sarah Karami, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4016 S Highway 97, Sand Springs, OK 74063 Phone: 918-245-6661 | |
Dr. April Holmes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 S Highway 97, Sand Springs, OK 74063 Phone: 918-245-9523 |